mardi 25 août 2015

Onco Actu du 25 août 2015

1. Biologie

Blood vessel cells help tumours evade the immune system [Karolinska Institutet]

Cancer cells programmed back to normal by US scientists [The Telegraph]

3.1 Tabac

What the US can learn from England's new stance on e-cigarettes [Vox]

3.3 Prévention - Vaccins

Rhode Island move to mandate HPV vaccine in schools faces criticism [Reuters]

3.4.1 Chimioprévention - aspirine

An aspirin a day – for years – may keep colon cancer away [Reuters]

5. Traitements

New Research On Ductal Carcinoma In Situ (DCIS) Brings Knowledge--Now We Need Understanding [Dr Len]

How should we treat stage 0 breast cancer? [Respectful Insolence]

An Easier Way to Treat Early-Stage Breast Cancer With Radiation [Wall Street Journal]

5.2 Pharma

Data From METEOR Pivotal Trial of Cabozantinib in Advanced Renal Cell Carcinoma Accepted as Late-Breaker Presentation in Presidential Session at European Cancer Congress 2015 [Exelixis]

5.2.1 Pharma - Partenariats

AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial [AstraZeneca]

5.2.3 Pharma - économie

Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO [Xconomy]

5.3 Traitements - FDA, EMA,...

FDA Grants Breakthrough Therapy Designation to Exelixis’ Cabozantinib for the Treatment of Renal Cell Carcinoma in Patients Who Received One Prior Therapy [Exelixis]

FDA and EMA accept regulatory applications for Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) for treatment of advanced squamous cell carcinoma of the lung [Boehringer Ingelheim]

6.10 Politiques

Next Steps in Developing the Precision Medicine Initiative [The White House]

6.11 Patients

The cancer therapy breakthrough that gives President Carter hope [Science]

Portraits of breast cancer patients at Norwich exhibition [BBC News]